SEC Tracker
Get the app

BioNexus Gene Lab BGLC

BioNexus signs AI healthcare deal with RYET

Form
8-K
Filed
Importance
Routine
  1. Exclusive Malaysian healthcare licence for CogniAI platform
  2. Issuance of 410,000 shares for $3.5M licence consideration
  3. 10% royalty on defined technology receipts
  4. Closing pending on technology acceptance and approvals

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when BioNexus Gene Lab files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (8071) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Aclarion ACON public float $4M, Jun 30, 2025
  2. Advanced Biomed ADVB public float $3M, Dec 31, 2025
  3. First Choice Healthcare Solutions FCHS public float $198K, Jun 30, 2025
  4. Ludwig Enterprises LUDG public float $10M, Jun 30, 2025
  5. CapForce CFOR public float $12M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.